InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Desai Veeral, Directeur de la Stratégie et du Développement. Director active across 1 company, notably agilon health, inc.. In total, 16 filings have been published. Split: 1 buy · 0 sell. History available since 14 September 2021. The latest transaction was filed on 15 April 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Desai Veeral
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
196,189 shares0Common StockSEC:0001628280-24-016653:0
11,956 sharesCommon StockSEC:0001628280-24-011773:0
Canonical exit: 12 Jun 2024 (T+90)
4,500 shares@ US$3.000.9% of flowCommon StockSEC:0001209191-23-028800:0
5,000 shares@ US$3.001.0% of flowCommon StockSEC:0001209191-23-025112:0
26,353 shares0Common StockSEC:0001209191-23-024666:0
22,710 shares@ US$3.004.7% of flowCommon StockSEC:0001209191-23-021209:0
60,000 shares@ US$3.0012.7% of flowCommon StockSEC:0001209191-23-019722:0
1,482 shares@ US$23.072.4% of flowCommon StockSEC:0001209191-22-051528:0
79,768 shares@ US$1.005.8% of flowCommon StockSEC:0001209191-22-043105:0
319,071 shares@ US$1.0023.4% of flowCommon StockSEC:0001209191-22-041801:0
106,357 shares@ US$1.000.0073% mcap15.4% of flowCommon StockSEC:0001209191-22-039598:0
79,568 shares@ US$1.005.9% of flowCommon StockSEC:0001209191-22-025550:0
106,357 shares@ US$1.008.0% of flowCommon StockSEC:0001209191-22-025160:0
16,255 shares0Common StockSEC:0001209191-22-025009:0
197,291 shares@ US$1.0014.5% of flowCommon StockSEC:0001209191-22-020015:0
121,001 shares@ US$1.008.3% of flowCommon StockSEC:0001209191-21-056200:0
16 of 16 declarations
About Desai Veeral
Desai Veeral is Directeur de la Stratégie et du Développement and Chief Strategy & Dev. Officer at agilon health, inc., listed on XNAS. The record shows 16 filings in total, and across the 16 sampled filings from 2021-09-15 to 2024-04-17, the most common transaction nature is Levée d'options, with buy and sell amounts of EUR 0.
